Bruker Expands Infection Detection Portfolio with Acquisition of Metagenomic mNGS DISQVER® Platform for Pathogenic Microorganisms in Blood
Go back to Bruker Expands Infection Detection Portfolio with Acquisition of Metagenomic mNGS DISQVER® Platform for Pathogenic Microorganisms in Blood| Bruker Corporation (NASDAQ: BRKR) | Delayed: 61.99 +0.41 (0.67%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $61.58 | 52 Week High | $29.85 | |||
| Open | $62.29 | 52 Week Low | $19.59 | |||
| Day High | $62.35 | P/E | 129.15 | |||
| Day Low | $60.91 | EPS | $0.48 | |||
| Volume | 311,988 | |||||
